The Importance of Needle Gauge for Pain During Injection of Local Anaesthetic

NCT ID: NCT02107729

Last Updated: 2016-07-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-02-28

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will investigate the influence of needle gauge on pain during injection of local anaesthetic. Healthy volunteers will be recruited, who will each receive three injections with either 21G, 23G or 27G subcutaneously on the abdomen. After each injection, the participants will be asked to evaluate the pain on a Visual analog scale (0-100 mm). It is anticipated that the pain will decrease with decreasing thickness of the needle. The aim of this study is to find a simple method for pain reduction that can be used in clinical practice.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Needlestick Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Needle gauge small

injection needle 23 G

Group Type EXPERIMENTAL

Large needle gauge lidocaine injection

Intervention Type PROCEDURE

21 G

Normal needle gauge lidocaine injection

Intervention Type PROCEDURE

23 G

Small needle gauge lidocaine injection

Intervention Type PROCEDURE

27 G

Needle gauge normal

injection needle 25 G

Group Type EXPERIMENTAL

Large needle gauge lidocaine injection

Intervention Type PROCEDURE

21 G

Normal needle gauge lidocaine injection

Intervention Type PROCEDURE

23 G

Small needle gauge lidocaine injection

Intervention Type PROCEDURE

27 G

Needle gauge large

injection needle 27 G

Group Type EXPERIMENTAL

Large needle gauge lidocaine injection

Intervention Type PROCEDURE

21 G

Normal needle gauge lidocaine injection

Intervention Type PROCEDURE

23 G

Small needle gauge lidocaine injection

Intervention Type PROCEDURE

27 G

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Large needle gauge lidocaine injection

21 G

Intervention Type PROCEDURE

Normal needle gauge lidocaine injection

23 G

Intervention Type PROCEDURE

Small needle gauge lidocaine injection

27 G

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18-65 years

Exclusion Criteria

* Kidney, heart or liver disease
* Eczema or psoriasis on injection site
* Neuropathy
* Regular use of painkillers
* Hypersensitivity of Lidocaine
* Pregnancy
* Diabetes
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

St. Olavs Hospital

OTHER

Sponsor Role collaborator

Norwegian University of Science and Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vilhjalmur Finsen, Prof md

Role: STUDY_DIRECTOR

Norwegian University of Science and Technology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Neuroscience, NTNU

Trondheim, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

References

Explore related publications, articles, or registry entries linked to this study.

Wago KJ, Skarsvag TI, Lundbom JS, Tangen LF, Ballo S, Hjelseng T, Finsen V. The importance of needle gauge for pain during injection of lidocaine. J Plast Surg Hand Surg. 2016;50(2):115-8. doi: 10.3109/2000656X.2015.1111223. Epub 2015 Nov 23.

Reference Type RESULT
PMID: 26595751 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2013/2297B

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Anesthetic Effect Duration Assessment
NCT01545765 COMPLETED PHASE4
Tenaculum Pain Control Study
NCT01421641 COMPLETED PHASE4